ProQR Therapeutics Creating RNA therapies for patients in need
On a mission
At ProQR, we are passionate about pushing the boundaries of science and technology to create innovative solutions for unmet medical needs. Our team is dedicated to conducting cutting-edge research and development in the RNA editing field to improve the lives of patients and families affected by genetic disorders.
We believe that every person deserves access to the best possible care, and we are committed to working together as a community to make that happen. Join us on our mission to make a real difference in the lives of those we serve.
Our scienceInternal link Working at ProQR
Latest press releases
Internal link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
Internal link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
Internal link ProQR to Present at Upcoming Scientific and Industry Conferences
ProQR Community News
Catching up with returning ProQRian René BeukemaCommunity news
Exploring why companies partner their technologyCommunity news
Today marks an expansion of the ProQR and Lilly partnershipCommunity news
ProQR & Eli Lilly and Company partnership
Since 2021 ProQR has partnered with Eli Lilly and Company focusing on the discovery, development, and commercialization of potential new using ProQR’s proprietary Axiomer® RNA editing platform.Internal link Read about our partnership